Charles Conover Talbot
Papers
1
Total Citations
9
H-Index
1
About
Dr. Charles Conover Talbot is a pioneering researcher in the field of non-invasive cancer diagnostics, with a particular focus on leveraging small non-coding RNAs for early detection. His most cited work introduces a groundbreaking, cost-effective test based on plasma protein functional effector sncRNAs (pfeRNAs) that can differentiate benign, suspicious, and malignant pulmonary nodules. This non-invasive approach addresses a critical clinical challenge: the need for definitive intervention in patients with early-stage lung cancers without resorting to invasive procedures. With 9 citations, this 2021 study has already demonstrated significant impact, offering a promising pathway to reduce unnecessary biopsies and improve patient outcomes. Dr. Talbot’s contributions lie at the intersection of molecular biology and clinical oncology, where his innovative use of pfeRNAs as biomarkers represents a notable achievement in precision medicine. His work continues to inspire researchers seeking accessible, accurate tools for cancer screening, underscoring his role as a key figure in advancing non-invasive liquid biopsy technologies.
Research Focus
Key Achievements
Top Papers
- 1